All results

107 results

• 1305-0023 (FIBRONEERTM ILD)

  This study is open to adults with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs). People who have a form of PF-ILD other than Idiopathic Pulmonary…

  Ages

  18 Years - N/A

  Sexes

  All

• A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Pts w/ MIBC

  The purpose of this study is to evaluate the anti-tumor effects of TAR-200 in combination with intravenous (IV) cetrelimab and IV cetrelimab alone. Bladder…

  Ages

  18 Years - N/A

  Sexes

  All

• ABRuPT2

  This is a prospective randomized multi-center study which will compare acute fluid resuscitation using a colloid strategy (LR + 5% Albumin) to a crystalloid…

  Ages

  18 Years - N/A

  Sexes

  All

• ABX Nail Study

  This prospective randomized clinical trial will compare outcomes between patients treated primarily with a prophylactic antibiotic coated nail and those…

  Ages

  18 Years - N/A

  Sexes

  All

• ACTIV-4d or Novel Experimental COVID Therapies Affecting Host Response (NECTAR)

  The overarching goal of the Master Protocol is to find effective strategies for inpatient management of patients with COVID-19. Therapeutic goals for patients…

  Ages

  18 Years - N/A

  Sexes

  All

• AD Sleep Disturbance

  The purpose of the study is to evaluate the effect of ruxolitinib cream on sleep disturbances with participants with Atopic Dermatitis. ### Inclusion…

  Ages

  18 Years - N/A

  Sexes

  All

• ALTA TIPS

  ALTA is a multicenter consortium focused on the management of portal hypertension. ALTA TIPS is a longitudinal observational study of patients who are…

  Ages

  18 Years - N/A

  Sexes

  All

• ANCHOR

  This study will evaluate the efficacy and safety of depemokimab (GSK3511294) in participants with CRSwNP. ### Inclusion criteria: * Participants with 18 years…

  Ages

  18 Years - N/A

  Sexes

  All

• ARGX-113-2007

  This study's purpose is to measure the treatment response from efgartigimod PH20 SC compared with placebo in participants with Idiopathic Inflammatory Myopathy…

  Ages

  18 Years - N/A

  Sexes

  All

• Abbott Next Generation Drug Eluting Stent 48mm Study (ABT NG DES 48)

  The purpose of this SPIRIT 48 study is to evaluate the safety and effectiveness of the ABT NG DES 48 in improving coronary artery luminal diameter in subjects…

  Ages

  18 Years - N/A

  Sexes

  All